2.0 g) in anhydrous tetrahydrofuran (10 mL), followed by the addition of ethyl bromoacetate (1.4 mL, 0.012 mol) at 0 °C. After 10 min of stirring, the reaction mixture was warmed and kept under stirring at room temperature for 1 h.
The reaction was quenched by the addition of saturated aqueous ammonium chloride (50 mL) at 0 °C and then extracted with ethyl acetate (200 mL). The organic layer was washed with brine, dried over sodium sulfate, and evaporated under reduced pressure to give yellowish oil that was purified by silica-gel chromatography to give the title compound as colorless oil, 2.4 g, 62% yield. Compound 2G. To a solution of compounds 9G (119 mg, 0.5 mmol) and coumarin 4a (242 mg, 0.6 mmol), and Nethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI) (115 mg, 0.6 mmol) in anhydrous N,Ndimethylformamide (DMF) (3 mL) was added 4-dimethylaminopyridine (DMAP) (31 mg, 0.25 mmol) at room temperature. After being stirred overnight (~15 h), the reaction mixture was extracted with ethyl acetate (50 mL), washed with saturated ammonium chloride aqueous solution (3 x 100 mL), dried over sodium sulfate, and evaporated under reduced pressure. Purification by silica-gel chromatography yielded the title compound as a yellowish solid, 205 mg, 80% yield. Spectral properties were in accordance with the data reported previously (Tobimatsu, et al. 2011 ).
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Compound 2S. The title compound was prepared according to the procedure described above from compound 9S and coumarin 4a, and isolated as a yellowish solid (75% yield Compound 3G. To a solution of compounds 9G (100 mg, 0.42 mmol) and nitrobenzofuran 5a (170 mg, 0.5 mmol), and EDCI (96 mg, 0.5 mmol) in anhydrous DMF (3 mL) was added DMAP (26 mg, 0.21 mmol) at room temperature. After being stirred overnight (~15 h), the reaction mixture was extracted with ethyl acetate (50 mL), washed with saturated aqueous ammonium chloride (3 x 100 mL), dried over sodium sulfate, and evaporated under reduced pressure. Purification by silica-gel chromatography yielded the title compound as an orange powder, 147 mg, 79% yield. Spectral properties were in accordance with the data reported previously (Tobimatsu, et al. 2011 ).
Compound 3S. The title compound was prepared according to the procedure described above from compound 9S
and nitrobenzofuran 5a, and isolated as an orange powder (80% yield (a and b) A section treated with DMAC-tagged monolignol probe 2G (a) and control section treated with non-conjugated DMAC dye 4b (b) at the same gain, confirming that developing cell walls are brighter in the labeled sample but that autofluorescence still contributes in unlabeled areas of the image. Scale bars denote 100 μm.
(c and d)
A section treated with NBD-tagged monolignol probe 3G (c) and control section treated with non-conjugated NBD dye 5b (d) at the same gain, confirming that developing cell walls are brighter in the labeled sample and that autofluorescence contributes almost nothing to the labeled image. This indicates a significant advantage in terms of brightness relative to autofluorescence for the NBD probe over the DMAC. Scale bars denote 100 μm. 
+ 3G Control
1 H (upper) and 13 C (lower) NMR spectra of compound 7S. 
